Codexis Inc. (CDXS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Codexis Inc. (CDXS:NASDAQ), powered by AI.

Current Price
$2.40
Sector
Healthcare
What is the Codexis Inc. stock price forecast?

Codexis Inc. is currently trading at $2.40. View real-time AI analysis on Alpha Lenz.

What is Codexis Inc. insider trading activity?

View the latest insider trading data for Codexis Inc. on Alpha Lenz.

What is Codexis Inc.'s P/E ratio?

View Codexis Inc.'s valuation metrics on Alpha Lenz.

Codexis Inc.

NASDAQ · CDXS
$2.40-0.01(-0.41%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Codexis Inc.'s future dividend policy...
Alpha Chat Insight

Codexis Inc.'s ROE is -74.9%. Explore profitability and growth together.

Ask for details

Company Overview

Codexis Inc. operates within the biotechnology sector, specializing in the engineering of enzymes and proteins to serve diverse industries. The company's primary function is to harness its proprietary technology platforms for the creation of specialized biocatalysts. These biocatalysts are instrumental in improving the efficiency and sustainability of chemical processes, particularly in pharmaceuticals and sustainable manufacturing. Codexis's technology is applied in the development of novel therapeutics, enhanced drug manufacturing processes, and the production of food and industrial chemicals with reduced environmental impact. Headquartered in Redwood City, California, the organization holds a prominent position in the market as a pioneer in protein engineering. Through partnerships with major pharmaceutical companies and other industry leaders, Codexis significantly contributes to the innovation landscape in enzyme application, driving advancements in health-based solutions and sustainable development across multiple sectors.

CEODr. Stephen George Dilly MBBS, Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees188

Company Statistics

FY 2025

Profile

N/AMarket Cap
$70.39MRevenue
0.00Shares Out
188Employees

Margins

86.73%Gross
-43.27%EBITDA
-54.46%Operating
-62.41%Pre-Tax
-62.47%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-20.22%Rev 3Yr
0.38%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-29.63%ROA
-74.88%ROE
-26.36%ROIC

Financial Health

$50.79MCash & Cash Equivalents
$46.48MNet Debt
192.50%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Codexis Inc. (ticker: CDXS) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 188 employees.

The current price is $2.4 with a P/E ratio of -x and P/B of -x.

ROE is -74.88% and operating margin is -54.46%. Annual revenue is $70M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Codexis Inc. (CDXS) Stock Forecast 2026 $2.40 — Price, Financials & Analyst Targets | Alpha Lenz